Description: Group Life COVID-19 Mortality Survey - Updated through December 2022

Description: The Group Life COVID-19 Mortality Survey gathers a high-level view of U.S. Group Term Life Insurance mortality results during the COVID-19 pandemic through June 2023, as compared to prior period baseline mortality results. This new report is an update to the survey report released in May 2023, which contained data through December 2022.

Description: The Group Life COVID-19 Mortality Survey gathers a high-level view of U.S. Group Term Life Insurance mortality results during the COVID-19 pandemic through September 2021, as compared to prior period baseline mortality results. This new report is an update to the survey report released in July 2021, which contained data through March 2021.

Description: View the report for the experience study "Group Life COVID-19 Mortality Survey - Updated through June 2023"

Description: The Group Life COVID-19 Mortality Survey gathers a high-level view of U.S. Group Term Life Insurance mortality results during the COVID-19 pandemic through March 2022, as compared to prior period baseline mortality results. This new report is an update to the survey report released in January 2022, which contained data through September 2021.

Description: The Mortality Improvement Survey Subcommittee of the Society's Committee on Life Insurance Mortality & Underwriting Surveys has completed its report on the results of a survey to examine mortality improvement practices with respect to life insurance pricing in both the US and Canada. A few questions were asked about functions other than pricing.

Description: The Mortality Improvement Survey Subcommittee of the Society's Committee on Life Insurance Mortality & Underwriting Surveys has completed its report on the results of a survey to examine mortality improvement practices with respect to reinsurance pricing in both the US and Canada. A few questions were asked about functions other than pricing.

Description: U.S. population death statistics and trends often occupy COVID-19 briefings and daily headlines. There are also publicly available mortality data sources for actuaries and others to perform their own analysis. Yet industry studies examining the impact of COVID-19 on insured populations are in their infancy. In this webcast, presenters will provide insights into how the life insured population is faring during COVID-19 by discussing the findings from two recent SOA research initiatives. LIMRA, RGA Reinsurance, the Society of Actuaries and TAI have collaborated on an effort to analyze the impact of COVID-19 on the individual life insurance industry’s mortality experience. Additionally, the SOA has surveyed insurers to gather a high-level view of U.S. Group Term Life Insurance mortality results during the COVID-19 pandemic and comparing them to pre-pandemic mortality levels.

Description: As part of its ongoing effort to provide useful information on COVID-19, the Society of Actuaries issued a brief survey to its Investment Section members to gain insight as to how COVID-19 is impacting investment professionals. The survey results are intended to help members compare their thinking and future expectations of COVID-19 with their peers.

Description: The Committee on Life Insurance Mortality and Underwriting Surveys of the Society of Actuaries Research Institute sent companies a survey in May of 2019 on mortality improvement practices. Note this survey was completed prior to the onset of COVID-19, so that issue was not addressed in this survey. The purpose of the survey was to examine mortality improvement practices with respect to life insurance and annuity pricing and financial projections in both the U.S. and Canada.